找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Brachytherapy; Techniques and Evide Yasuo Yoshioka,Jun Itami,Takashi Nakano Book 2019 Springer Nature Singapore Pte Ltd. 2019 Uterine cervi

[復(fù)制鏈接]
樓主: FROM
31#
發(fā)表于 2025-3-27 00:14:05 | 只看該作者
32#
發(fā)表于 2025-3-27 03:59:03 | 只看該作者
33#
發(fā)表于 2025-3-27 07:53:19 | 只看該作者
34#
發(fā)表于 2025-3-27 13:30:04 | 只看該作者
Brachytherapy APBI: Japanese Experience and Asian Trendrving surgery, cylindrical resection, is especially different in that it leaves no cavity in the breast. The CTV after Asian surgery, therefore, needs special consideration. Consensus on surgical approach and CTV for small breast is still open for discussion. In this chapter we focus on the surgical techniques and evidences from Asian countries.
35#
發(fā)表于 2025-3-27 16:50:13 | 只看該作者
36#
發(fā)表于 2025-3-27 21:50:24 | 只看該作者
37#
發(fā)表于 2025-3-28 01:08:11 | 只看該作者
Japanese Brachytherapy in the?World Fractionated regimen of HDR intracavitary brachytherapy of cervical cancer was established in the 1970s based upon an extensive analysis of clinical findings of the patients undergoing HDR and LDR brachytherapies. It was the first report deriving HDR and LDR equivalent doses not from theoretical co
38#
發(fā)表于 2025-3-28 04:09:00 | 只看該作者
Moving on from?LDR to HDRigh-dose-rate (HDR) intracavitary brachytherapy was developed to overcome some drawbacks of LDR brachytherapy (e.g., exposure of the medical staff and long treatment time). After biological effects including fractionation effects of HDR brachytherapy were determined by basic and clinical studies, HD
39#
發(fā)表于 2025-3-28 10:07:16 | 只看該作者
Intracavitary Brachytherapy from 2D to 3Dt 100?years. ICBT has been performed based on the two-dimensional (2D) planning with the use of orthogonal X-ray films for a long time. Doses are prescribed at point A according to the classical or modified Manchester systems. Recently, a dramatic shift has occurred from 2D to three-dimensional (3D)
40#
發(fā)表于 2025-3-28 14:03:28 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 14:44
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
钟山县| 阿拉尔市| 科技| 罗源县| 依兰县| 南华县| 龙山县| 吉首市| 逊克县| 望奎县| 门源| 城口县| 乐陵市| 突泉县| 宜兰县| 西安市| 桓台县| 红河县| 杭州市| 会理县| 洪泽县| 千阳县| 绥中县| 清远市| 五家渠市| 呼伦贝尔市| 嘉鱼县| 基隆市| 高青县| 长寿区| 玛多县| 微博| 胶南市| 隆回县| 新邵县| 西林县| 吉首市| 平潭县| 衢州市| 南开区| 玛多县|